Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A
Article in Molecular Medicine (June 2023)
The most recent citing publications are shown below. View all 41 publications that cite this research output on Dimensions.
Improved Intrvenous Lentiviral Gene Therapy Based on Endothelial-specific Factor VIII for Hemophilia A
Preprint in Research Square (March 2023)
Improved Long-term In Vivo Lentiviral Gene Therapy for Chronic Granulomatous Disease
Preprint in Research Square (February 2023)